QHSLab, Inc. Files 8-K Report

Ticker: USAQ · Form: 8-K · Filed: May 2, 2024 · CIK: 856984

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

QHSLab filed an 8-K on May 2nd covering Reg FD and financials. Formerly USA Equities.

AI Summary

On May 2, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and its fiscal year ends on December 31st. Its principal business address is in West Palm Beach, Florida.

Why It Matters

This 8-K filing provides an update on QHSLab, Inc.'s regulatory disclosures and financial reporting, which is crucial for investors to understand the company's current status and compliance.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report for disclosure and financial statements, not indicating any immediate significant operational or financial distress.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing indicates a Regulation FD Disclosure but does not detail the specific information released under this regulation within the provided text.

What types of financial statements and exhibits are included in the filing?

The filing states that 'Financial Statements and Exhibits' are included, but the specific nature or content of these documents is not detailed in the provided text.

When did QHSLab, Inc. change its name from USA EQUITIES CORP.?

The filing indicates the date of name change from USA EQUITIES CORP. to QHSLab, Inc. was November 19, 2015.

What is QHSLab, Inc.'s state of incorporation and fiscal year end?

QHSLab, Inc. is incorporated in Nevada and its fiscal year ends on December 31st.

What is the business address of QHSLab, Inc.?

The business address of QHSLab, Inc. is 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.

Filing Stats: 645 words · 3 min read · ~2 pages · Grade level 10 · Accepted 2024-05-02 08:30:26

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 2, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing